Annual ROE
-48.69%
-6.90%-16.51%
December 31, 2023
Summary
- As of February 8, 2025, BOLT annual return on equity is -48.69%, with the most recent change of -6.90% (-16.51%) on December 31, 2023.
- During the last 3 years, BOLT annual ROE has fallen by -106.56% (-184.14%).
- BOLT annual ROE is now -166.98% below its all-time high of 72.69%, reached on December 31, 2018.
Performance
BOLT ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-64.69%
-6.97%-12.08%
September 30, 2024
Summary
- As of February 8, 2025, BOLT quarterly return on equity is -64.69%, with the most recent change of -6.97% (-12.08%) on September 30, 2024.
- Over the past year, BOLT quarterly ROE has dropped by -6.97% (-12.08%).
- BOLT quarterly ROE is now -195.62% below its all-time high of 67.65%, reached on December 31, 2020.
Performance
BOLT Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
BOLT ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -16.5% | -12.1% |
| 3 y3 years | -184.1% | -12.1% |
| 5 y5 years | -167.0% | -12.1% |
BOLT ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -16.5% | +64.2% | -78.9% | at low |
| 5 y | 5-year | -173.2% | +64.2% | -195.6% | +83.5% |
| alltime | all time | -167.0% | +64.2% | -195.6% | +83.5% |
Bolt Biotherapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -64.69%(+12.1%) |
| Jun 2024 | - | -57.72%(+18.1%) |
| Mar 2024 | - | -48.86%(+0.6%) |
| Dec 2023 | -48.69%(+16.5%) | -48.57%(+7.4%) |
| Sep 2023 | - | -45.23%(+2.2%) |
| Jun 2023 | - | -44.25%(+3.7%) |
| Mar 2023 | - | -42.66%(+1.4%) |
| Dec 2022 | -41.79% | -42.09%(+1.6%) |
| Sep 2022 | - | -41.42%(+7.5%) |
| Jun 2022 | - | -38.53%(+6.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -36.16%(-25.2%) |
| Dec 2021 | -135.83%(-334.7%) | -48.37%(-34.4%) |
| Sep 2021 | - | -73.77%(-38.1%) |
| Jun 2021 | - | -119.16%(-69.7%) |
| Mar 2021 | - | -393.22%(-681.3%) |
| Dec 2020 | 57.87%(-13.0%) | 67.65%(+4.3%) |
| Sep 2020 | - | 64.86%(+2.4%) |
| Jun 2020 | - | 63.37%(+61.5%) |
| Mar 2020 | - | 39.25%(+92.2%) |
| Dec 2019 | 66.50%(-8.5%) | 20.42% |
| Dec 2018 | 72.69% | - |
FAQ
- What is Bolt Biotherapeutics annual return on equity?
- What is the all time high annual ROE for Bolt Biotherapeutics?
- What is Bolt Biotherapeutics annual ROE year-on-year change?
- What is Bolt Biotherapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Bolt Biotherapeutics?
- What is Bolt Biotherapeutics quarterly ROE year-on-year change?
What is Bolt Biotherapeutics annual return on equity?
The current annual ROE of BOLT is -48.69%
What is the all time high annual ROE for Bolt Biotherapeutics?
Bolt Biotherapeutics all-time high annual return on equity is 72.69%
What is Bolt Biotherapeutics annual ROE year-on-year change?
Over the past year, BOLT annual return on equity has changed by -6.90% (-16.51%)
What is Bolt Biotherapeutics quarterly return on equity?
The current quarterly ROE of BOLT is -64.69%
What is the all time high quarterly ROE for Bolt Biotherapeutics?
Bolt Biotherapeutics all-time high quarterly return on equity is 67.65%
What is Bolt Biotherapeutics quarterly ROE year-on-year change?
Over the past year, BOLT quarterly return on equity has changed by -6.97% (-12.08%)